0001209191-17-023918.txt : 20170331 0001209191-17-023918.hdr.sgml : 20170331 20170331173156 ACCESSION NUMBER: 0001209191-17-023918 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170330 FILED AS OF DATE: 20170331 DATE AS OF CHANGE: 20170331 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAPLAN GILLA CENTRAL INDEX KEY: 0001247024 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 17731579 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 FORMER NAME: FORMER CONFORMED NAME: KAPLAN GILLA PHD DATE OF NAME CHANGE: 20030625 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-03-30 0 0000816284 CELGENE CORP /DE/ CELG 0001247024 KAPLAN GILLA C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 1 0 0 0 Common Stock 2017-03-30 4 S 0 14033 123.83 D 73109 D The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $123.76 to $123.92, inclusive. The reporting person undertakes to provide to Celgene Corporation (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. /s/ Peter N. Kellogg, Attorney in Fact 2017-03-31